Abdul Rani, Mohammed Fauzi (2000) Primary Pulmonary Hypertension. Medical Journal Malaysia, 55 (4). pp. 529-537. ISSN 0300-5283
PDF
Restricted to Repository staff only Download (430kB) | Request a copy |
Abstract
Primary pulmonary hypertension(PPH) is a rare disease. The annual incidence in the West is 1-2 cases per million population per year. A recent WHO symposium in 1998 has produced a consensus on classification, methods of screening, risk assessment and treatment. PPH is a diagnosis of exclusion after all other secondary causes of pulmonary hypertension are ruled out. Current treatment strategy involves acute vasodilator drug trial where positive responders are treated with high dose calcium channel blockers and anticoagulation. Those who do not show positive response may be commenced on intravenous prostacyclin. Surgical treatment is one option for patients with severe PPH or for symptomatic relief. Prognosis in general is very poor.
Item Type: | Article (Journal) |
---|---|
Additional Information: | 3204/5876 |
Uncontrolled Keywords: | primary pulmonary hypertension |
Subjects: | R Medicine > R Medicine (General) |
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button): | Kulliyyah of Medicine > Department of Internal Medicine |
Depositing User: | Prof Dr Mohammed Fauzi Abdul Rani |
Date Deposited: | 26 Jun 2013 08:21 |
Last Modified: | 26 Jun 2013 08:21 |
URI: | http://irep.iium.edu.my/id/eprint/5876 |
Actions (login required)
View Item |